Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Pediatric Nephrology
Published in: Pediatric Nephrology 12/2019

01-12-2019 | Systemic Lupus Erythematosus | Clinical Quiz

An adolescent with lupus nephritis presenting with fever, lymphadenomegaly, and arthralgia: Answers

Authors: Gizem Yildiz, Meral Torun Bayram, Alper Soylu, Salih Kavukçu

Published in: Pediatric Nephrology | Issue 12/2019

Login to get access

Excerpt

Our patient developed fever, painful lymphadenomegaly, and elevated acute phase markers shortly after introduction of mycophenolate mofetil (MMF) for treatment of lupus nephritis. Her symptoms developed acutely and regressed in the same manner after discontinuation of MMF. …
Literature
1.
Maes B, Oellerich M, Ceuppens JL, Armstrong VW, Evenepoel P, Kuypers D, Messiaen T, Shipkova M, Wieland E, Vanrenterghem Y (2002) A new acute inflammatory syndrome related to the introduction of mycophenolate mofetil in patients with Wegener’s granulomatosis. Nephrol Dial Transplant 17:923–926CrossRef
2.
Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C (1997) Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. Transplantation 63:39–47CrossRef
3.
Querfeld U, Weber LT (2018) Mycophenolate mofetil for sustained remission in nephrotic syndrome. Pediatr Nephrol 33:2253–2265CrossRef
4.
Jones RB, Hiemstra TF, Ballarin J, Blockmans DE, Brogan P, Bruchfeld A, Cid MC, Dahlsveen K, de Zoysa J, Espigol-Frigolé G, Lanyon P, Peh CA, Tesar V, Vaglio A, Walsh M, Walsh D, Walters G, Harper L, Jayne D, European Vasculitis Study Group (EUVAS) (2019) Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial. Ann Rheum Dis 78:399–405CrossRef
5.
Mok CC (2015) Mycophenolate mofetil for lupus nephritis: an update. Expert Rev Clin Immunol 11:1353–1364CrossRef
6.
Villarroel MC, Hidalgo M, Jimeno A (2009) Mycophenolate mofetil: an update. Drugs Today (Barc) 45:521–532
7.
Hochegger K, Gruber J, Lhotta K (2006) Acute inflammatory syndrome induced by mycophenolate mofetil in a patient following kidney transplantation. Am J Transplant 6:852–854CrossRef
8.
Konon I, Cronin ME, Ryan LM (2008) Acute inflammatory syndrome following introduction of mycophenolate mofetil in a patient with systemic lupus erythematosus. Arthritis Rheum 59:754–756CrossRef
9.
Loock J, Lamprecht P, Gross WL (2012) Acute inflammatory syndrome with elevated procalcitonin induced by mycophenolate sodium. J Rheumatol 39:658–659CrossRef
10.
Maruyama Y, Sadahira T, Mitsui Y, Wada K, Tanimoto R, Nishimura S, Kobayashi Y, Watanabe T, Nasu Y, Araki M (2018) Acute inflammatory syndrome paradoxically induced by de novo purine inhibitors synthesis before renal transplantation: a case report and review of the literature. Transplant Proc 50:895–897CrossRef
11.
Shrestha D, Dhakal AK, Shiva RK, Shakya A, Shah SC, Shakya H (2013) Systemic lupus erythematosus and granulomatous lymphadenopathy. BMC Pediatr 13:179CrossRef
12.
Gru AA, O’Malley DP (2018) Autoimmune and medication induced lymphadenopathies. Semin Diagn Pathol 35:34–43CrossRef
13.
Pepe F, Disma S, Teodoro C, Pepe P, Magro G (2016) Kikuchi-Fujimoto disease: a clinicopathologic update. Pathologica 108:120–129PubMed
Metadata
Title
An adolescent with lupus nephritis presenting with fever, lymphadenomegaly, and arthralgia: Answers
Authors
Gizem Yildiz
Meral Torun Bayram
Alper Soylu
Salih Kavukçu
Publication date
01-12-2019
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 12/2019
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-019-04308-5

Other articles of this Issue 12/2019

Pediatric Nephrology 12/2019 Go to the issue

Brief Report

Infrequent tacrolimus-induced nephrotoxicity in French patients with steroid-dependent nephrotic syndrome

Educational Review

Hypertensive crisis in children and adolescents

Review

What’s new in autoinflammation?

Clinical Quiz

Hypokalemia in a pediatric patient on continuous renal replacement therapy: Questions

Educational Review

Vitamin D and cardiovascular disease in chronic kidney disease

Review

The role of CD47 in pathogenesis and treatment of renal ischemia reperfusion injury